SEC Info - Alexandra Global Master Fund Ltd, et al. - ‘SC 13G/A’ on 2/14/05 re: Generex Biotechnology Corp

SEC Info℠

Home

Help

Please Sign In

Alexandra Global Master Fund Ltd, et al. – ‘SC 13G/A’ on 2/14/05 re: Generex Biotechnology Corp

On: Monday, 2/14/05, at 4:19pm ET · Accession #: 950123-5-1798 · File #: 5-62471

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/14/05  Alexandra Global Master Fund Ltd  SC 13G/A               1:16K  Generex Biotechnology Corp        RR Donnelley/FA
          Alexandra Investment Management LLC
          Dimitri Sogoloff
          Mikhail A. Filimonov

Amendment to Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G/A    Amendment No.1 to Schedule 13G                         9     34K

Document Table of Contents

Page	(sequential)	\|	(alphabetic)	Top
			Alternative Formats (Word, et al.) Address of Issuer's Principal Executive Offices: Address of Principal Business Office: Alexandra Certification: Identification and Classification of Members of the Group: Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: Name of Issuer: Names of Persons Filing: Notice of Dissolution of Group: Ownership: Ownership of Five Percent or Less of a Class: Ownership of More Than Five Percent on Behalf of Another Person: Place of Organization or Citizenship: This Schedule is filed pursuant to Rule 13d-1(c) by Alexandra, Management, Filimonov and Sogoloff Title of Class of Securities:
1	1st Page - Filing Submission
6	Item 1(a). Name of Issuer:
"	Item 1(b). Address of Issuer's Principal Executive Offices:
"	Item 2(a). Names of Persons Filing:
"	Item 2(b). Address of Principal Business Office:
"	Item 2(c). Place of Organization or Citizenship:
"	Item 2(d). Title of Class of Securities:
"	Item 3. This Schedule is filed pursuant to Rule 13d-1(c) by Alexandra, Management, Filimonov and Sogoloff
"	Item 4. Ownership:
"	Alexandra
8	Item 5. Ownership of Five Percent or Less of a Class:
"	Item 6. Ownership of More Than Five Percent on Behalf of Another Person:
"	Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company:
"	Item 8. Identification and Classification of Members of the Group:
"	Item 9. Notice of Dissolution of Group:
"	Item 10. Certification:

SC 13G/A 1st Page of 9 TOC ↑Top Previous Next ↓Bottom Just 1st
 
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 1 OF 9 PAGES

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

 UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)*

 Generex Biotechnology Corporation
(Name of Issuer)

 Common Stock, $.001 par value
(Title of Class of Securities)

 371485103
(CUSIP Number)

 December 31, 2004
 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 
is filed:                                                                       

[ ]  Rule 13d-1(b)                                                              
[X]  Rule 13d-1(c)                                                              
[ ]  Rule 13d-1(d)                                                              

*The remainder of this cover page shall be filled out for a reporting person's  
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter           
disclosures provided in a prior cover page.                                     

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of   
1934 ("Act") or otherwise subject to the liabilities of that section of the Act 
but shall be subject to all other provisions of the Act (however, see the       
Notes).                                                                         

SC 13G/A 2nd Page of 9 TOC 1st Previous Next ↓Bottom Just 2nd
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 2 OF 9 PAGES

--------------------------------------------------------------------------------
1     NAME OF REPORTING PERSON                                      
 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

Alexandra Global Master Fund Ltd.             
(No I.R.S. ID Number)                         
--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ]       
                                                            (B) [ ] (See Item 6)

--------------------------------------------------------------------------------
3     SEC USE ONLY                                                  

--------------------------------------------------------------------------------
4     CITIZENSHIP OR PLACE OF ORGANIZATION                          

British Virgin Islands                        
--------------------------------------------------------------------------------
NUMBER OF               5  SOLE VOTING POWER                          
SHARES                                                              
BENEFICIALLY                      -0-                                   
      OWNED BY              ----------------------------------------------------
EACH                  6  SHARED VOTING POWER                      
REPORTING                                                             
PERSON                                                              
  WITH:                    166,667 shares of Common Stock (See Item 4)
                            ----------------------------------------------------

   7  SOLE DISPOSITIVE POWER

 -0-

                            ----------------------------------------------------
     8  SHARED DISPOSITIVE POWER

                           166,667 shares of Common Stock (See Item 4)

--------------------------------------------------------------------------------
9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  

166,667 shares of Common Stock (See Item 4)   

--------------------------------------------------------------------------------
      10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
        (SEE INSTRUCTIONS)                                           [ ]

--------------------------------------------------------------------------------
11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)             

0.5% (See Item 4)                             

--------------------------------------------------------------------------------
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

CO                                            
--------------------------------------------------------------------------------

SC 13G/A 3rd Page of 9 TOC 1st Previous Next ↓Bottom Just 3rd
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 3 OF 9 PAGES

--------------------------------------------------------------------------------
1     NAME OF REPORTING PERSON                                      
 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

Alexandra Investment Management, LLC          
13-4092583                                    

--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ]       
                                                            (B) [ ] (See Item 6)

--------------------------------------------------------------------------------
3     SEC USE ONLY                                                  

--------------------------------------------------------------------------------
4     CITIZENSHIP OR PLACE OF ORGANIZATION                          

Delaware                                      

--------------------------------------------------------------------------------
NUMBER OF              5  SOLE VOTING POWER                         
SHARES                                                            

BENEFICIALLY                     -0-                                    
      OWNED BY             -----------------------------------------------------
EACH                 6  SHARED VOTING POWER                     
REPORTING                                                           
PERSON                                                            
  WITH:                    166,667 shares of Common Stock (See Item 4)
                           -----------------------------------------------------

   7  SOLE DISPOSITIVE POWER

-0-   

                           -----------------------------------------------------
     8  SHARED DISPOSITIVE POWER

                             166,667 shares of Common Stock (See Item 4)
--------------------------------------------------------------------------------
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON    

166,667 shares of Common Stock (See Item 4) 
--------------------------------------------------------------------------------
10      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES           
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

--------------------------------------------------------------------------------
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)               

0.5% (See Item 4)                             

--------------------------------------------------------------------------------
12      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                     

OO                                            

--------------------------------------------------------------------------------

SC 13G/A 4th Page of 9 TOC 1st Previous Next ↓Bottom Just 4th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 4 OF 9 PAGES

--------------------------------------------------------------------------------

1     NAME OF REPORTING PERSON                                      
 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

Mikhail A. Filimonov                          

--------------------------------------------------------------------------------
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (A)[ ]       
                                                             (B)[ ] (See Item 6)

--------------------------------------------------------------------------------
3     SEC USE ONLY                                                  

--------------------------------------------------------------------------------
4     CITIZENSHIP OR PLACE OF ORGANIZATION                          

U.S.                                          

--------------------------------------------------------------------------------
NUMBER OF              5  SOLE VOTING POWER                         
SHARES                                                            
BENEFICIALLY                     -0-                                    
      OWNED BY             -----------------------------------------------------
EACH                 6  SHARED VOTING POWER                     
REPORTING                                                           
  PERSON                   166,667 shares of Common Stock (See Item 4)
       WITH:               -----------------------------------------------------

  7 SOLE DISPOSITIVE POWER

-0-   

                           -----------------------------------------------------
     8  SHARED DISPOSITIVE POWER

                           166,667 shares of Common Stock (See Item 4)
--------------------------------------------------------------------------------
9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  

166,667 shares of Common Stock (See Item 4)   
--------------------------------------------------------------------------------
      10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)                                  [ ] 

--------------------------------------------------------------------------------
11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)             

0.5% (See Item 4)                             

--------------------------------------------------------------------------------
12    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                   

IN                                            
--------------------------------------------------------------------------------

SC 13G/A 5th Page of 9 TOC 1st Previous Next ↓Bottom Just 5th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 5 OF 9 PAGES

--------------------------------------------------------------------------------
1     NAME OF REPORTING PERSON                                      
 I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

Dimitri Sogoloff                              
--------------------------------------------------------------------------------

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) [ ]       
                                                            (B) [ ] (See Item 6)

--------------------------------------------------------------------------------
3     SEC USE ONLY                                                  

--------------------------------------------------------------------------------
4     CITIZENSHIP OR PLACE OF ORGANIZATION                          

U.S.                                          
--------------------------------------------------------------------------------
NUMBER OF              5  SOLE VOTING POWER                         
SHARES                                                            
BENEFICIALLY                       -0-                                  
      OWNED BY             -----------------------------------------------------
EACH                 6  SHARED VOTING POWER                     
REPORTING                                                           
  PERSON                   166,667 shares of Common Stock (See Item 4)
       WITH:               -----------------------------------------------------

   7  SOLE DISPOSITIVE POWER

-0-   

                           -----------------------------------------------------
     8  SHARED DISPOSITIVE POWER

                           166,667 shares of Common Stock (See Item 4)
--------------------------------------------------------------------------------
9     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  

166,667 shares of Common Stock (See Item 4) 
--------------------------------------------------------------------------------
10    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES         
     CERTAIN SHARES (SEE INSTRUCTIONS)                         [ ]

--------------------------------------------------------------------------------
11    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)             

0.5% (See Item 4)                             
--------------------------------------------------------------------------------
12    TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)                   

IN                                            
--------------------------------------------------------------------------------

SC 13G/A 6th Page of 9 TOC 1st Previous Next ↓Bottom Just 6th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 6 OF 9 PAGES

Item 1(a).        Name of Issuer:                                               

    Generex Biotechnology Corporation (the "Issuer")

Item 1(b).        Address of Issuer's Principal Executive Offices:              

33 Harbour Square                           
Suite 202                                   
Toronto, Ontario                            
Canada  M5J  2G2                            

Item 2(a).        Names of Persons Filing:                                      

   Alexandra Global Master Fund Ltd. ("Alexandra")
       Alexandra Investment Management, LLC ("Management")
Mikhail A. Filimonov ("Filimonov")          
Dimitri Sogoloff ("Sogoloff")               

Item 2(b).        Address of Principal Business Office:                         

          Alexandra - Citco Building, Wickams Cay, P.O. Box 662,
Road Town, Tortola, British Virgin Islands  
        Management - 767 Third Avenue, 39th Floor, New York,
New York 10017                              
       Filimonov - 767 Third Avenue, 39th Floor, New York,
New York 10017                              
      Sogoloff - 767 Third Avenue, 39th Floor, New York,
New York 10017                              

Item 2(c).        Place of Organization or Citizenship:                         

Alexandra - British Virgin Islands          
Management - Delaware                       
Filimonov - U.S.                            
Sogoloff - U.S.                             

Item 2(d).        Title of Class of Securities:                                 

               Common Stock, $.001 par value per share, of the Issuer (the
"Common Stock")                             

Item 2(e).        CUSIP Number: 371485103                                       

Item 3.           This Schedule is filed pursuant to Rule 13d-1(c) by           
 Alexandra, Management, Filimonov and Sogoloff

Item 4.           Ownership:                                                    

(a)   Amount Beneficially Owned:            

Alexandra: 166,667 shares*      
Management: 166,667 shares*     
Filimonov: 166,667 shares*      
Sogoloff: 166,667 shares*       

(b)   Percent of Class:                     

Alexandra: 0.5%*                
Management: 0.5%*               
Filimonov:0.5%*               
Sogoloff: 0.5%*               

SC 13G/A 7th Page of 9 TOC 1st Previous Next ↓Bottom Just 7th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 7 OF 9 PAGES

           (Based on 34,807,448 shares of Common Stock
                     outstanding, as of October 31, 2004, as stated by the
                   Issuer in its Quarterly Report on Form 10-Q for the
quarter ended October 31, 2004) 

      (c)   Number of Shares as to which the Person has:

                (i)     sole power to vote or to direct the vote

                   -0-

                   (ii)    shared power to vote or to direct the vote:

               166,667 shares of Common Stock*

              (iii)   sole power to dispose or to direct the
disposition of  

                   -0-

                (iv)    shared power to dispose or to direct the
disposition of  

               166,667 shares of Common Stock*

*The shares of Common Stock reported as beneficially owned by Alexandra are     
166,667 of Common Stock which Alexandra has the right to acquire upon exercise  
of a Warrant entitling the holder to purchase shares of Common Stock.           

Management serves as investment advisor to Alexandra. By reason of such         
relationship, Management may be deemed to share voting and dispositive power    
over the shares of Common Stock owned by Alexandra. Management disclaims        
beneficial ownership of the shares of Common Stock listed as beneficially owned 
by Alexandra or any other person reporting on this Schedule.                    

Filimonov serves as the Chairman, the Chief Executive Officer, a Managing Member
and the Chief Investment Officer of Management. Sogoloff serves as the          
President, a Managing Member and the Chief Information Officer of Management. By
reason of such relationships, each of Filimonov and Sogoloff may be deemed to   
share voting and dispositive power over the shares of Common Stock listed as    
beneficially owned by Management. Filimonov and Sogoloff each disclaims         
beneficial ownership of the shares of Common Stock listed as beneficially owned 
by Management or any other person reporting on this Schedule.                   

SC 13G/A 8th Page of 9 TOC 1st Previous Next ↓Bottom Just 8th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 8 OF 9 PAGES

Item 5.           Ownership of Five Percent or Less of a Class:                 

                  If this statement is being filed to report the fact that as of
                  the date hereof each of the Reporting Persons ceased to be the
              beneficial owner of more than five percent of the class of
securities, check the following [X]         

Item 6.           Ownership of More Than Five Percent on Behalf of Another      
Person:                                     

Not applicable                              

Item 7.           Identification and Classification of the Subsidiary which     
         Acquired the Security Being Reported on by the Parent
Holding Company:                            

Not applicable                              

Item 8.           Identification and Classification of Members of the Group:    

Not applicable                              

Item 9.           Notice of Dissolution of Group:                               

Not applicable                              

Item 10.          Certification:                                                

By signing below each signatory certifies that, to the best of its knowledge and
belief, the securities referred to above were not acquired and are not held for 
the purpose of or with the effect of changing or influencing the control of the 
issuer of the securities and were not acquired and are not held in connection   
with or as a participant in any transaction having that purpose or effect.      

Exhibits:                                                                       

 Exhibit I: Joint Filing Agreement, dated as of April 15, 2004, by and
among Alexandra, Management, Filimonov and Sogoloff (incorporated herein by     
reference to the exhibit with the same number filed with Schedule 13G by the    
persons reporting on this Amendment No. 1).                                     

SC 13G/A Last Page of 9 TOC 1st Previous Next ↓Bottom Just 9th
SCHEDULE 13G                                                                    
CUSIP NO. 371485103                                            PAGE 9 OF 9 PAGES

 SIGNATURE

By signing below each signatory certifies that, to the best of its  
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the   
control of the issuer of the securities and were not acquired and are not held  
in connection with or as a participant in any transaction having that purpose or
effect.                                                                         

Dated February 14, 2005 ALEXANDRA GLOBAL MASTER FUND LTD.                       

             By: ALEXANDRA INVESTMENT MANAGEMENT, LLC,
Investment Advisor  

        By: /s/ Mikhail A. Filimonov
        ----------------------------
Mikhail A. Filimonov
  Title: Managing Member

        ALEXANDRA INVESTMENT MANAGEMENT, LLC

By: /s/ Mikhail A. Filimonov
----------------------------
Mikhail A. Filimonov        
Title: Managing Member      

/s/ Mikhail A. Filimonov    
----------------------------
Mikhail A. Filimonov        

/s/ Dimitri Sogoloff        
----------------------------
Dimitri Sogoloff

SC 13G/A	1st Page of 9	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13G/A	2nd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13G/A	3rd Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13G/A	4th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13G/A	5th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13G/A	6th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13G/A	7th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13G/A	8th Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13G/A	Last Page of 9	TOC	1st	Previous	Next	↓Bottom	Just 9th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13G/A’ Filing	Date	First	Last	Other Filings

Filed on:	2/14/05	9		SC 13G/A
	12/31/04	1
	10/31/04	7		10-Q
	4/15/04	8
				List all Filings

↑Top

Filing Submission 0000950123-05-001798 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Alexandra Global Master Fund Ltd, et al. – ‘SC 13G/A’ on 2/14/05 re: Generex Biotechnology Corp

On: Monday, 2/14/05, at 4:19pm ET · Accession #: 950123-5-1798 · File #: 5-62471

Previous ‘SC 13G’: ‘SC 13G/A’ on 2/14/05 · Next: ‘SC 13G/A’ on 2/14/05 · Latest: ‘SC 13G/A’ on 2/16/10

Amendment to Statement of Beneficial Ownership — Schedule 13GFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Amendment to Statement of Beneficial Ownership — Schedule 13G
Filing Table of Contents